Stability LPL II (Completed)
A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
- Medicine
- darapladib
- Population
- ASCVD
- Phase
- III
- Starting year
- 2009
- More information
- ClinivalTrials.gov